Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges.

ABSTRACT: Gliomas, which account for nearly a quarter of all primary CNS tumors, present significant contemporary therapeutic challenges, particularly the highest-grade variant (glioblastoma multiforme), which has an especially poor prognosis. These difficulties are due to the tumor's aggressiveness and the adverse effects of radio/chemotherapy on the brain. Stem cell therapy is an exciting area of research being explored for several medical issues. Neural stem cells, normally present in the subventricular zone and the hippocampus, preferentially migrate to tumor masses. Thus, they have two main advantages: They can minimize the side effects associated with systemic radio/chemotherapy while simultaneously maximizing drug delivery to the tumor site. Another feature of stem cell therapy is the variety

SUBMITTER: Benmelouka AY 

PROVIDER: S-EPMC7956497 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature